How a single tablet helped Natco beat sector blues
Natco launched the first generic version of Tamilflu- A proprietary drug of Roche.02-06-2017
02-06-2017
Natco Pharma Q4 profit surges nearly threefold to Rs176.7 crore
Natco Pharma's consolidated net profit for the fourth quarter rose to Rs176.7 crore, from Rs62.8 crore a year ago, on the back of robust sales in the US market30-05-2017
Press Release
NATCO records INR 2078.9 Crore total consolidated revenue and INR 486.0 Crore of profit, after tax, for the full year ended March 201730-05-2017
Audited Financial Results For The Quarter And Year Ended 31St March, 2017
Audited Financial Results for the quarter and year ended 31st march, 201730-05-2017
Earnings Call For The Quarter And Year Ended 31St March, 2017
The Company will host an Earnings Call with Investors / Analysts at 11.00 a.m. on 31st May, 2017 to disseminate Financial Results of the company for the quarter and year ended 31st March, 2017. A copy of the same is enclosed for your ready reference.26-05-2017
Natco Pharma gets environmental nod for API plant expansion in Telangana
Project is expected to employ 1,200 persons directly and 300 persons indirectly after the expansion23-05-2017
Natco Pharma gets green nod for Rs 480-cr expansion project in Telangana
Clearance is subject to compliance of certain conditions; Project expected to create 1,500 jobs21-05-2017
Closure of Trading Window
pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 TRADING WINDOW for dealing in the securities of the Company will be closed from 20th May, 2017 to 01st June, 2017 (both days inclusive). Trading window will be opened from 02nd June, 2017.20-05-2017
Board Meeting On 30Th May, 2017
inter alia, to consider and approve the Audited Financial Results for the quarter and year ended 31st March, 201720-05-2017